Blood samples may unlock secrets of a common epilepsy

NCT ID NCT03400371

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study aims to find the genetic causes of juvenile myoclonic epilepsy (JME) by collecting blood samples from over 1,000 people with JME across the UK, Europe, and North America. Researchers will compare their DNA to samples from 2,000 healthy controls. The goal is to improve treatments and enable earlier detection of the condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could point toward better treatments and earlier detection for juvenile myoclonic epilepsy.
What could go wrong
This is an observational study, not a treatment trial. It may not directly lead to new therapies, and genetic findings can take years to translate into clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JUVENILE MYOCLONIC EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Charles University

    RECRUITING

    Prague, 116 36, Czechia

  • Commissione Genetica Lega Italiana contro l'Epilepssia

    RECRUITING

    Roma, 00198, Italy

  • Danish National Epilepsy Centre

    RECRUITING

    Dianalund, 4293, Denmark

  • Hospital for Sick Kids

    RECRUITING

    Toronto, Ontario, M5G 0A4, Canada

  • King's College Hospital NHS Trust

    RECRUITING

    London, SE5 9RS, United Kingdom

  • Mount Sinai-Beth Israel Medical Center

    COMPLETED

    New York, New York, 10003, United States

  • Nationwide Children's Hospital

    COMPLETED

    Columbus, Ohio, 43125, United States

  • Royal London Hospital

    RECRUITING

    London, E1 1BZ, United Kingdom

  • St Luke's Roosevelt Hospital

    COMPLETED

    New York, New York, 10025, United States

  • St Thomas' Hospital

    RECRUITING

    London, SE1 9HT, United Kingdom

  • Swansea University

    RECRUITING

    Swansea, SA2 8PP, United Kingdom

  • Tallinn Children's Hospital

    RECRUITING

    Tallinn, 13419, Estonia

  • University Robert Debré

    RECRUITING

    Paris, 75019, France

  • Vestre Viken Health Trust, Oslo

    RECRUITING

    Drammen, 3004, Norway

  • Walton Centre for Neurology and Neurosurgery

    RECRUITING

    Liverpool, L9 7LJ, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.